PBLS 8-K 2026-09-15

Parabilis Medicines, Inc. (PBLS) 8-K dated 2026-09-15 — accession 0001193125-26-391952.

Parabilis Medicines, Inc. (PBLS) common stock.

Parabilis Medicines, Inc. filed a 8-K on 2026-09-15. Accession 0001193125-26-391952.

This 8-K covers: Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PBLS revenue for 2026-06-30 was $148.0K. Net income was -$52.5M.

Not investment advice. The PBLS SEC hub lists recent forms. The stock page is the research view.